Related references
Note: Only part of the references are listed.A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
Hagma H. Workel et al.
CANCER IMMUNOLOGY RESEARCH (2019)
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
Laura M. McLane et al.
Annual Review of Immunology (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
CXCR5+CD8 T Cells: Protective or Pathogenic?
Kristen M. Valentine et al.
FRONTIERS IN IMMUNOLOGY (2019)
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
Hanjie Li et al.
CELL (2019)
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen et al.
NATURE MEDICINE (2018)
Bias, robustness and scalability in single-cell differential expression analysis
Charlotte Soneson et al.
NATURE METHODS (2018)
The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis
Cristina Albanesi et al.
FRONTIERS IN IMMUNOLOGY (2018)
PD-1+CD8+ T cells are clonally expanding effectors in human chronic inflammation
Alessandra Petrelli et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Nicolo Costantino Brembilla et al.
FRONTIERS IN IMMUNOLOGY (2018)
Risankizumab: an anti-IL-23 antibody for the treatment of psoriasis
Isabel M. Haugh et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
CD49a Expression Defines Tissue-Resident CD8+ T Cells Poised for Cytotoxic Function in Human Skin
Stanley Cheuk et al.
IMMUNITY (2017)
Clinically resolved psoriatic lesions contain psoriasis-specific IL-17-producing αβ T cell clones
Tiago R. Matos et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
Andrew Blauvelt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparatore-controlled VOYAGE 2 trial
Kristian Reich et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
Kristian Reich et al.
LANCET (2017)
Runx3 programs CD8+ T cell residency in non-lymphoid tissues and tumours
J. Justin Milner et al.
NATURE (2017)
Scater: pre-processing, quality control, normalization and visualization of single-cell RNA-seq data in R
Davis J. McCarthy et al.
BIOINFORMATICS (2017)
CD19+B cell subsets in the peripheral blood and skin lesions of psoriasis patients and their correlations with disease severity
J. Lu et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2016)
Bioenergetic Insufficiencies Due to Metabolic Alterations Regulated by the Inhibitory Receptor PD-1 Are an Early Driver of CD8+ T Cell Exhaustion
Bertram Bengsch et al.
IMMUNITY (2016)
ABC transporters and NR4A1 identify a quiescent subset of tissue-resident memory T cells
Chandra Sekhar Boddupalli et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
T cell fate and clonality inference from single-cell transcriptomes
Michael J. T. Stubbington et al.
NATURE METHODS (2016)
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Itay Tirosh et al.
SCIENCE (2016)
CXCL13 antibody for the treatment of autoimmune disorders
Ekaterina Klimatcheva et al.
BMC IMMUNOLOGY (2015)
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chih-Hao Chang et al.
CELL (2015)
Melanocyte antigen triggers autoimmunity in human psoriasis
Akiko Arakawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells
Rei Watanabe et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
Nikolaos Patsoukis et al.
NATURE COMMUNICATIONS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Epidermal Th22 and Tc17 Cells Form a Localized Disease Memory in Clinically Healed Psoriasis
Stanley Cheuk et al.
JOURNAL OF IMMUNOLOGY (2014)
Transcriptome Analysis of Psoriasis in a Large Case-Control Sample: RNA-Seq Provides Insights into Disease Mechanisms
Bingshan Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The IL-17A-Producing CD8+ T-Cell Population in Psoriatic Lesional Skin Comprises Mucosa-Associated Invariant T Cells and Conventional T Cells
Marcel B. M. Teunissen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Normalization of RNA-seq data using factor analysis of control genes or samples
Davide Risso et al.
NATURE BIOTECHNOLOGY (2014)
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Roberto Lande et al.
NATURE COMMUNICATIONS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Distribution and Compartmentalization of Human Circulating and Tissue-Resident Memory T Cell Subsets
Taheri Sathaliyawala et al.
IMMUNITY (2013)
CD8+ T Cells in the Lesional Skin of Atopic Dermatitis and Psoriasis Patients Are an Important Source of IFN-γ, IL-13, IL-17, and IL-22
Dirkjan Hijnen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Brodalumab, an Anti-Interleukin-17-Receptor Antibody for Psoriasis
Kim A. Papp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Anti-Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Craig Leonardi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Assessment of the Psoriatic Transcriptome in a Large Sample: Additional Regulated Genes and Comparisons with In Vitro Models
Johann E. Gudjonsson et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Larry Gold et al.
PLOS ONE (2010)
Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis
Pieter C. M. Res et al.
PLOS ONE (2010)
Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis
Wolfgang Hueber et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Tc17 CD8 T Cells: Functional Plasticity and Subset Diversity
Hung-Rong Yen et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines
Consuelo Ortega et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Stepwise Development of MAIT Cells in Mouse and Human
Emmanuel Martin et al.
PLOS BIOLOGY (2009)
Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells
Michelle A. Lowes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Ectopic lymphoid neogenesis in psoriatic arthritis
Juan D. Canete et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
The vast majority of CLA+ T cells are resident in normal skin
Rachael A. Clark et al.
JOURNAL OF IMMUNOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Ablation of CD8 and CD4 T cell responses by high viral loads
MJ Fuller et al.
JOURNAL OF IMMUNOLOGY (2003)
Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes
EJ Kunkel et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Perforin and granzyme B may contribute to skin inflammation in atopic dermatitis and psoriasis
N Yawalkar et al.
BRITISH JOURNAL OF DERMATOLOGY (2001)
Share Paper
